Genomic structure of the promoters of the human estrogen receptor-α gene demonstrate changes in chromatin structure induced by AP2γ

被引:33
作者
Schuur, ER [1 ]
McPherson, LA [1 ]
Yang, GP [1 ]
Weigel, RJ [1 ]
机构
[1] Stanford Univ, Sch Med, Dept Surg, Stanford, CA 94305 USA
关键词
D O I
10.1074/jbc.M009001200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Expression of human estrogen receptor-alpha (ER alpha) involves the activity from several promoters that give rise to alternate untranslated 5' exons, However, the genomic locations of the alternate 5' exons have not been reported previously, We have developed a contig map of the human ER alpha gene that includes all of the known alternate 5' exons, By using S1 nuclease and 5'-rapid amplification of cDNA ends, the cap sites for the alternate ER alpha transcripts E and H were identified. DNase I-hypersensitive sites specific to ER alpha -positive cells were associated with each of the cap sites. A DNase I-hypersensitive site, HS1, was localized to binding sites for AP2 in the untranslated region of exon 1 and was invariably present in the chromatin structure of ER alpha -positive cells, Overexpression of AP2 gamma in human mammary epithelial cells generated the HS1-hypersensitive site. The ER alpha promoter was induced by AP2 gamma in mammary epithelial cells, and trans-activation was dependent upon the region of the promoter containing the HS1 site. These results demonstrate that AP2 gamma trans-activates the ER alpha gene in hormone-responsive tumors by Inducing changes in the chromatin structure of the ER alpha promoter. These data are further evidence for a critical role for AP2 in the oncogenesis of hormone-responsive breast cancers.
引用
收藏
页码:15519 / 15526
页数:8
相关论文
共 36 条
[1]   HUMAN PAPILLOMA-VIRUS DNAS IMMORTALIZE NORMAL HUMAN MAMMARY EPITHELIAL-CELLS AND REDUCE THEIR GROWTH-FACTOR REQUIREMENTS [J].
BAND, V ;
ZAJCHOWSKI, D ;
KULESA, V ;
SAGER, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (01) :463-467
[2]  
BARRETTLEE PJ, 1987, CANCER RES, V47, P6653
[3]  
BRADBEER JW, 1983, CLIN ONCOL, V9, P31
[4]  
Carmeci C, 1997, AM J PATHOL, V150, P1563
[5]   Auto-regulation of the estrogen receptor promoter [J].
Castles, CG ;
Oesterreich, S ;
Hansen, R ;
Fuqua, SAW .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1997, 62 (2-3) :155-163
[6]  
DECONINCK EC, 1995, MOL CELL BIOL, V15, P2191
[7]   Identification of a new isoform of the human estrogen receptor-alpha (hER-α) that is encoded by distinct transcripts and that is able to repress hER-α activation function 1 [J].
Flouriot, G ;
Brand, H ;
Denger, S ;
Metivier, R ;
Kos, M ;
Reid, G ;
Sonntag-Buck, V ;
Gannon, F .
EMBO JOURNAL, 2000, 19 (17) :4688-4700
[8]   Differentially expressed messenger RNA isoforms of the human estrogen receptor-α gene are generated by alternative splicing and promoter usage [J].
Flouriot, G ;
Griffin, C ;
Kenealy, M ;
Sonntag-Buck, V ;
Gannon, F .
MOLECULAR ENDOCRINOLOGY, 1998, 12 (12) :1939-1954
[9]   Determination of transcription start sites in the human estrogen receptor gene and identification of a novel, tissue-specific, estrogen receptor-mRNA isoform [J].
Grandien, K .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1996, 116 (02) :207-212
[10]   ESTROGEN TARGET TISSUE DETERMINES ALTERNATIVE PROMOTER UTILIZATION OF THE HUMAN ESTROGEN-RECEPTOR GENE IN OSTEOBLASTS AND TUMOR-CELL LINES [J].
GRANDIEN, K ;
BACKDAHL, M ;
LJUNGGREN, O ;
GUSTAFSSON, JA ;
BERKENSTAM, A .
ENDOCRINOLOGY, 1995, 136 (05) :2223-2229